Physician profile
Michael James Garitty
NPI 1962815332
$30,296.32
in general payments reported to CMS, 2019-2025
9 companies · $678 in 2025
The $678 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $12K · 2021: $1,933 · 2022: $57.31 · 2023: $1,946 · 2024: $1,675 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,726 · Food and Beverage: $1,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,725.88 |
| Food and Beverage | $1,572.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $21,521.08 | 2019-2020 | |
| Stryker Corporation | $7,291.08 | 2020-2025 | Mako, Insignia, Triathlon |
| Peerless Surgical INC. | $820.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $266.41 | 2021-2023 | Persona |
| Orthalign INC | $118.60 | 2025 | Orthalign Plus |
| Pacira Therapeutics, INC. | $112.62 | 2020 | |
| Wright Medical Technology, INC. | $93.67 | 2019 | |
| Curonix LLC | $52.85 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pacira Pharmaceuticals Incorporated | $20.01 | 2024 | Exparel, Iovera, Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Garitty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.